Medicare Enrolled

Dr. Caryn Borger, MD

Optician · Florham Park, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
15 JAMES ST, Florham Park, NJ 07932
9733776868
In practice since 2006 (19 years)
NPI: 1669569414 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borger

Dr. Caryn Borger is an optician specialist in Florham Park, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Borger performed 1,791 Medicare services across 231 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borger received a total of $67,891 from 51 pharmaceutical and/or device companies across 881 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 36% volume in NJ $67,891 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,791
Medicare services
Top 36% in NJ for optician
231
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,320 $18 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
357 $101 $200
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
57 $27 $95
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
37 $67 $132
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $126 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$67,891
Total received (2018-2024)
Avg $9,699/year across 7 years
Top 3% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
881
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$58,887 (86.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,005 (13.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,242
2023
$3,155
2022
$21,347
2021
$3,671
2020
$14,158
2019
$18,861
2018
$3,458

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,648
Lilly USA, LLC
$327
Amgen Inc.
$171
Novo Nordisk Inc
$169
Abbott Laboratories
$147
Amneal Pharmaceuticals LLC
$136
Corcept Therapeutics
$96
Xeris Pharmaceuticals, Inc.
$79
Radius Health, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$53
Astellas Pharma US Inc
$42
PFIZER INC.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
SANOFI-AVENTIS U.S. LLC
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Mannkind Corporation
$31
Amphastar Pharmaceuticals, Inc.
$31
Medtronic, Inc.
$21
Dexcom, Inc.
$21
Neurocrine Biosciences, Inc.
$16
Insulet Corporation
$16
Alexion Pharmaceuticals, Inc.
$15
Exeltis, USA Inc.
$14
Top 3 companies account for 66.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$47,163
AbbVie Inc.
$6,922
AbbVie, Inc.
$3,171
ABBVIE INC.
$2,526
Lilly USA, LLC
$1,601
Amneal Pharmaceuticals LLC
$705
Amgen Inc.
$671
Boehringer Ingelheim Pharmaceuticals, Inc.
$514
Abbott Laboratories
$417
SANOFI-AVENTIS U.S. LLC
$394
Radius Health, Inc.
$370
PFIZER INC.
$310
Mannkind Corporation
$302
Shire North American Group Inc
$266
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$219
Xeris Pharmaceuticals, Inc.
$201
Dexcom, Inc.
$191
Bayer Healthcare Pharmaceuticals Inc.
$161
IBSA Pharma Inc.
$156
Ipsen Biopharmaceuticals, Inc
$150
Medtronic MiniMed, Inc.
$145
MannKind Corporation
$125
Corcept Therapeutics
$124
Bayer HealthCare Pharmaceuticals Inc.
$119
Insulet Corporation
$99
Merck Sharp & Dohme Corporation
$96
Alexion Pharmaceuticals, Inc.
$60
Senseonics, Incorporated
$58
DEXCOM, INC.
$56
Tandem Diabetes Care, Inc.
$53
Gemini Laboratories, LLC
$53
Alfasigma USA, Inc.
$52
Astellas Pharma US Inc
$42
Janssen Pharmaceuticals, Inc
$39
Medtronic, Inc.
$34
Rhythm Pharmaceuticals, Inc.
$34
VIVUS LLC
$31
Amphastar Pharmaceuticals, Inc.
$31
VIVUS, Inc.
$30
Ultragenyx Pharmaceutical Inc.
$28
Zealand Pharma US, Inc.
$25
Althera Pharmaceuticals LLC
$25
Currax Pharmaceuticals LLC
$18
Neurocrine Biosciences, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$14
Eisai Inc.
$14
Exeltis, USA Inc.
$14
CeQur Corporation
$13
Amryt Pharma Holdings Ltd
$12
Orexigen Therapeutics, Inc.
$11
Aytu BioScience, Inc
$11
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · Belviq · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Eversense · FIASP · FORTEO · FREESTYLE LIBRE · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · HUMULIN R 500 · INVOKANA · Imcivree · JANUVIA · JARDIANCE · Kerendia · Korlym · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Natesto · Norditropin · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · Qsymia · RECORLEV · RYBELSUS · Repatha · Roszet · Rybelsus · SLYND · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Sogroya · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Veozah · Victoza · Wegovy · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in NJ.

Looking for an optician specialist in Florham Park?
Compare opticians in the Florham Park area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
8,489
Per 100K population
1663.3
County median income
$134,929
Nearest hospital
COOPERMAN BARNABAS MEDICAL CENTER
3.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Borger is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Borger experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Borger performed 1,320 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borger receive payments from pharmaceutical companies?
Yes. Dr. Borger received a total of $67,891 from 51 companies across 881 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borger's costs compare to other opticians in Florham Park?
Dr. Borger's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →